Ghent University Academic Bibliography

Journal Article
A1
open access

Natural antibodies : protecting role of IgM in glioblastoma and brain tumours

Shubham Semwal, Rabah Boukherroub, Savvas Savvides (UGent) and Julie Bouckaert

(2021) CURRENT PHARMACEUTICAL DESIGN. 27(45). p.4515-4529

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68

Add to list

Journal Article
A1
open access

Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients

Eline Abma, Emmelie Stock (UGent) , Ward De Spiegelaere (UGent) , Leen Van Brantegem (UGent) , Katrien Vanderperren (UGent) , Yicheng Ni, Matthijs Vynck (UGent) , Sylvie Daminet (UGent) , Kaat De Clercq and Hilde De Rooster (UGent)

(2019) SCIENTIFIC REPORTS. 9.

Add to list

A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers

Eline Abma, Ward De Spiegelaere (UGent) , Katrien Vanderperren (UGent) , Emmelie Stock (UGent) , Leen Van Brantegem (UGent) , Ine Cornelis (UGent) , Sylvie Daminet (UGent) , Y Ni, Matthijs Vynck (UGent) , Glenn Verstraete (UGent) , et al.

(2018) VETERINARY AND COMPARATIVE ONCOLOGY. 16(4). p.467-477

Add to list

A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory

Julie Schatteman, Dirk Van Gestel, Dieter Berwouts, Werner De Gersem (UGent) , Geert De Kerf, Wilfried De Neve (UGent) , Bie De Ost, Ana Maria Luiza Olteanu (UGent) , Sylvie Rottey (UGent) , Tom Vercauteren (UGent) , et al.

(2018) STRAHLENTHERAPIE UND ONKOLOGIE. 194(8). p.727-736

Add to list

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

Lucas Moreno, Hubert Caron, Birgit Geoerger, Angelika Eggert, Gudrun Schleiermacher, Penelope Brock, Dominique Valteau-Couanet, Louis Chesler, Johannes Schulte, Katleen De Preter (UGent) , et al.

(2017) EXPERT OPINION ON DRUG DISCOVERY. 12(8). p.801-811

Add to list

ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice

Ammar Kurdi, Matthias Cleenewerck, Christel Vangestel, Sophie Lyssens, Wim Declercq (UGent) , Jean-Pierre Timmermans, Sigrid Stroobants, Koen Augustyns, Guido RY De Meyer, Pieter Van Der Veken, et al.

(2017) BIOCHEMICAL PHARMACOLOGY. 138. p.150-162

Add to list

Journal Article
A1
open access

Neutropenia as an adverse event following vaccination : results from randomized clinical trials in healthy adults and systematic review

Vincent Muturi-Kioi, David Lewis, Odile Launay, Geert Leroux-Roels (UGent) , Alessandra Anemona, Pierre Loulergue, Caroline L Bodinham, Annelies Aerssens, Nicola Groth, Allan Saul, et al.

(2016) PLOS ONE. 11(8).

Add to list

Journal Article
A1
open access

Targeting the tumor microenvironment to enhance antitumor immune responses

Kevin Van Der Jeught, Lukasz Bialkowski, Lidia Daszkiewicz, Katrijn Broos, Cleo Goyvaerts, Dries Renmans, Sandra Van Lint (UGent) , Carlo Heirman, Kris Thielemans and Karine Breckpot

(2015) ONCOTARGET. 6(3). p.1359-1381

Add to list

Hepatitis B core-based virus-like particles to present heterologous epitopes

Kenny Roose (UGent) , Sarah De Baets (UGent) , Bert Schepens (UGent) and Xavier Saelens (UGent)

(2013) EXPERT REVIEW OF VACCINES. 12(2). p.183-198

Academic Bibliography

Natural antibodies : protecting role of IgM in glioblastoma and brain tumours

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients

A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers

A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory

Accelerating drug development for neuroblastoma - New drug development strategy : an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice

Neutropenia as an adverse event following vaccination : results from randomized clinical trials in healthy adults and systematic review

Targeting the tumor microenvironment to enhance antitumor immune responses

Hepatitis B core-based virus-like particles to present heterologous epitopes

Contents

Support

Contact